0002099941-26-000002.txt : 20261001 0002099941-26-000002.hdr.sgml : 20261001 20261001123837 ACCESSION NUMBER: 0002099941-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261001 DATE AS OF CHANGE: 20261001 EFFECTIVENESS DATE: 20261001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amani Therapeutics, Inc. CENTRAL INDEX KEY: 0002099941 ORGANIZATION NAME: EIN: 393302644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-599589 FILM NUMBER: 261430001 BUSINESS ADDRESS: STREET 1: 40 10TH AVENUE STREET 2: FLOOR 7 CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (646) 597-6980 MAIL ADDRESS: STREET 1: 40 10TH AVENUE STREET 2: FLOOR 7 CITY: NEW YORK STATE: NY ZIP: 10014 D 1 primary_doc.xml X0708 D LIVE 0002099941 Amani Therapeutics, Inc. 40 10TH AVENUE FLOOR 7 NEW YORK NY NEW YORK 10014 (646) 597-6980 DELAWARE None None Corporation true 2025 Alice Lee 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Executive Officer -- RTW Holdings VI, LLC 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Promoter Robert Swoboda 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Executive Officer Lauren Cuje 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Director Peter Fong 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Director Connor Williams 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Director Other Health Care Decline to Disclose 06b false 2026-09-16 false true false 0 59999999 34999999 25000000 false 5 0 0 0 false Amani Therapeutics, Inc. Robert Swoboda Robert Swoboda Chief Operating Officer 2026-09-29